Clinical characteristics limiting the durability of humoral response to BNT162b2 in patients with solid cancer
Vincenzo Di Noia, Fulvia Pimpinelli, Davide Renna, Vittoria Barberi, Raul Pellini, Aldo Morrone, Diana Giannarelli, Francesco Cognetti
Topics & Concepts
MedicineImmunogenicityCancerCohortProspective cohort studyClinical trialAntibodyInternal medicineOncologyImmunologySARS-CoV-2 and COVID-19 ResearchCancer Immunotherapy and BiomarkersCOVID-19 and healthcare impacts